{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:49:10Z","timestamp":1792702150268,"version":"4.5.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T00:00:00Z","timestamp":1637539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T00:00:00Z","timestamp":1637539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["C32070910"],"award-info":[{"award-number":["C32070910"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["C31872731"],"award-info":[{"award-number":["C31872731"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["C31470839"],"award-info":[{"award-number":["C31470839"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1038\/s41423-021-00801-w","type":"journal-article","created":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T03:05:38Z","timestamp":1637550338000},"page":"92-107","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["STING signaling activation inhibits HBV replication and attenuates the severity of liver injury and HBV-induced fibrosis"],"prefix":"10.1038","volume":"19","author":[{"given":"Yuqi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyun","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziteng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijie","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhao","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,22]]},"reference":[{"key":"801_CR1","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1016\/S0140-6736(18)31865-8","volume":"392","author":"WK Seto","year":"2018","unstructured":"Seto WK, Lo YR, Pawlotsky JM, Yuen MF. Chronic hepatitis B virus infection. Lancet. 2018;392:2313\u201324.","journal-title":"Lancet."},{"key":"801_CR2","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","volume":"384","author":"C Trepo","year":"2014","unstructured":"Trepo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet. 2014;384:2053\u201363.","journal-title":"Lancet."},{"key":"801_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","volume":"65","author":"M Parola","year":"2019","unstructured":"Parola M, Pinzani M. Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues. Mol Asp Med. 2019;65:37\u201355.","journal-title":"Mol Asp Med."},{"key":"801_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nri3623","volume":"14","author":"A Pellicoro","year":"2014","unstructured":"Pellicoro A, Ramachandran P, Iredale JP, Fallowfield JA. Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat Rev Immunol. 2014;14:181\u201394.","journal-title":"Nat Rev Immunol"},{"key":"801_CR5","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1136\/gutjnl-2015-309809","volume":"64","author":"M Nassal","year":"2015","unstructured":"Nassal M. HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B. Gut. 2015;64:1972\u201384.","journal-title":"Gut."},{"key":"801_CR6","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.drudis.2015.01.008","volume":"20","author":"M Ahmed","year":"2015","unstructured":"Ahmed M, Wang F, Levin A, Le C, Eltayebi Y, Houghton M, et al. Targeting the Achilles heel of the hepatitis B virus: a review of current treatments against covalently closed circular DNA. Drug Discov Today. 2015;20:548\u201361.","journal-title":"Drug Discov Today."},{"key":"801_CR7","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.dld.2009.12.003","volume":"42","author":"I Lenci","year":"2010","unstructured":"Lenci I, Marcuccilli F, Tisone G, Di Paolo D, Tariciotti L, Ciotti M, et al. Total and covalently closed circular DNA detection in liver tissue of long-term survivors transplanted for HBV-related cirrhosis. Dig Liver Dis. 2010;42:578\u201384.","journal-title":"Dig Liver Dis"},{"key":"801_CR8","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1002\/jmv.22014","volume":"83","author":"PN Cheng","year":"2011","unstructured":"Cheng PN, Liu WC, Tsai HW, Wu IC, Chang TT, Young KC. Association of intrahepatic cccDNA reduction with the improvement of liver histology in chronic hepatitis B patients receiving oral antiviral agents. J Med Virol. 2011;83:602\u20137.","journal-title":"J Med Virol."},{"key":"801_CR9","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.jhep.2017.02.026","volume":"66","author":"F Tacke","year":"2017","unstructured":"Tacke F. Targeting hepatic macrophages to treat liver diseases. J Hepatol. 2017;66:1300\u201312.","journal-title":"J Hepatol."},{"key":"801_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5604\/16652681.1226814","volume":"16","author":"A Altamirano-Barrera","year":"2017","unstructured":"Altamirano-Barrera A, Barranco-Fragoso B, Mendez-Sanchez N. Management strategies for liver fibrosis. Ann Hepatol. 2017;16:48\u201356.","journal-title":"Ann Hepatol."},{"key":"801_CR11","doi-asserted-by":"publisher","first-page":"7269150","DOI":"10.1155\/2020\/7269150","volume":"2020","author":"Y Tao","year":"2020","unstructured":"Tao Y, Wang N, Qiu T, Sun X. The role of autophagy and NLRP3 inflammasome in liver fibrosis. Biomed Res Int. 2020;2020:7269150.","journal-title":"Biomed Res Int."},{"key":"801_CR12","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.immuni.2019.03.012","volume":"50","author":"A Mantovani","year":"2019","unstructured":"Mantovani A, Dinarello CA, Molgora M, Garlanda C. Interleukin-1 and related cytokines in the regulation of inflammation and immunity. Immunity. 2019;50:778\u201395.","journal-title":"Immunity."},{"key":"801_CR13","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.3389\/fimmu.2019.02014","volume":"10","author":"L Barbier","year":"2019","unstructured":"Barbier L, Ferhat M, Salam\u00e9 E, Robin A, Herbelin A, Gombert JM, et al. Interleukin-1 family cytokines: keystones in liver inflammatory diseases. Front Immunol. 2019;10:2014.","journal-title":"Front Immunol"},{"key":"801_CR14","doi-asserted-by":"publisher","first-page":"L165","DOI":"10.1152\/ajplung.00275.2019","volume":"318","author":"TR Karhadkar","year":"2020","unstructured":"Karhadkar TR, Chen W, Gomer RH. Attenuated pulmonary fibrosis in sialidase-3 knockout (Neu3(-\/-)) mice. Am J Physiol Lung Cell Mol Physiol. 2020;318:L165\u2013L179.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"801_CR15","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.1172\/JCI125669","volume":"129","author":"G Chen","year":"2019","unstructured":"Chen G, Sun L, Kato T, Okuda K, Martino MB, Abzhanova A, et al. IL-1beta dominates the promucin secretory cytokine profile in cystic fibrosis. J Clin Invest. 2019;129:4433\u201350.","journal-title":"J Clin Invest"},{"key":"801_CR16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/hep.29406","volume":"67","author":"G Li","year":"2018","unstructured":"Li G, Zhu Y, Shao D, Chang H, Zhang X, Zhou D, et al. Recombinant covalently closed circular DNA of hepatitis B virus induces long-term viral persistence with chronic hepatitis in a mouse model. Hepatology. 2018;67:56\u201370.","journal-title":"Hepatology."},{"key":"801_CR17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nri3665","volume":"14","author":"A Iwasaki","year":"2014","unstructured":"Iwasaki A, Pillai PS. Innate immunity to influenza virus infection. Nat Rev Immunol. 2014;14:315\u201328.","journal-title":"Nat Rev Immunol."},{"key":"801_CR18","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/ni.3157","volume":"16","author":"M Altfeld","year":"2015","unstructured":"Altfeld M, Gale MJ. Innate immunity against HIV-1 infection. Nat Immunol. 2015;16:554\u201362.","journal-title":"Nat Immunol."},{"key":"801_CR19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1146\/annurev-immunol-070119-115052","volume":"38","author":"MM Hu","year":"2020","unstructured":"Hu MM, Shu HB. Innate immune response to cytoplasmic DNA: mechanisms and diseases. Annu Rev Immunol. 2020;38:79\u201398.","journal-title":"Annu Rev Immunol."},{"key":"801_CR20","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1038\/s41388-019-1108-8","volume":"39","author":"MK Thomsen","year":"2020","unstructured":"Thomsen MK, Skouboe MK, Boularan C, Vernejoul F, Lioux T, Leknes SL, et al. The cGAS-STING pathway is a therapeutic target in a preclinical model of hepatocellular carcinoma. Oncogene. 2020;39:1652\u201364.","journal-title":"Oncogene."},{"key":"801_CR21","doi-asserted-by":"publisher","first-page":"9369","DOI":"10.1128\/JVI.79.15.9369-9380.2005","volume":"79","author":"SF Wieland","year":"2005","unstructured":"Wieland SF, Chisari FV. Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol. 2005;79:9369\u201380.","journal-title":"J Virol."},{"key":"801_CR22","doi-asserted-by":"publisher","first-page":"7269","DOI":"10.1128\/JVI.79.11.7269-7272.2005","volume":"79","author":"M Isogawa","year":"2005","unstructured":"Isogawa M, Robek MD, Furuichi Y, Chisari FV. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J Virol. 2005;79:7269\u201372.","journal-title":"J Virol."},{"key":"801_CR23","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1016\/j.jhep.2016.01.028","volume":"64","author":"MK Maini","year":"2016","unstructured":"Maini MK, Gehring AJ. The role of innate immunity in the immunopathology and treatment of HBV infection. J Hepatol. 2016;64:S60\u2013S70.","journal-title":"J Hepatol."},{"key":"801_CR24","doi-asserted-by":"publisher","first-page":"111591","DOI":"10.1016\/j.ejmech.2019.111591","volume":"182","author":"X Cui","year":"2019","unstructured":"Cui X, Zhang R, Cen S, Zhou J. STING modulators: predictive significance in drug discovery. Eur J Med Chem. 2019;182:111591.","journal-title":"Eur J Med Chem."},{"key":"801_CR25","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature07317","volume":"455","author":"H Ishikawa","year":"2008","unstructured":"Ishikawa H, Barber GN. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature. 2008;455:674\u20138.","journal-title":"Nature."},{"key":"801_CR26","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1126\/science.1232458","volume":"339","author":"L Sun","year":"2013","unstructured":"Sun L, Wu J, Du F, Chen X, Chen ZJ. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science. 2013;339:786\u201391.","journal-title":"Science."},{"key":"801_CR27","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/ni.1932","volume":"11","author":"L Unterholzner","year":"2010","unstructured":"Unterholzner L, Keating SE, Baran M, Horan KA, Jensen SB, Sharma S, et al. IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol. 2010;11:997\u20131004.","journal-title":"Nat Immunol."},{"key":"801_CR28","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/ni.2091","volume":"12","author":"Z Zhang","year":"2011","unstructured":"Zhang Z, Yuan B, Bao M, Lu N, Kim T, Liu YJ. The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells. Nat Immunol. 2011;12:959\u201365.","journal-title":"Nat Immunol."},{"key":"801_CR29","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41586-019-1006-9","volume":"567","author":"X Gui","year":"2019","unstructured":"Gui X, Yang H, Li T, Tan X, Shi P, Li M, et al. Autophagy induction via STING trafficking is a primordial function of the cGAS pathway. Nature. 2019;567:262\u20136.","journal-title":"Nature."},{"key":"801_CR30","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1038\/s41418-018-0251-z","volume":"26","author":"D Liu","year":"2019","unstructured":"Liu D, Wu H, Wang C, Li Y, Tian H, Siraj S, et al. STING directly activates autophagy to tune the innate immune response. Cell Death Differ. 2019;26:1735\u201349.","journal-title":"Cell Death Differ"},{"key":"801_CR31","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1080\/15548627.2016.1235124","volume":"12","author":"J Han","year":"2016","unstructured":"Han J, Bae J, Choi CY, Choi SP, Kang HS, Jo EK, et al. Autophagy induced by AXL receptor tyrosine kinase alleviates acute liver injury via inhibition of NLRP3 inflammasome activation in mice. Autophagy. 2016;12:2326\u201343.","journal-title":"Autophagy."},{"key":"801_CR32","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1080\/15548627.2015.1058473","volume":"11","author":"J Lodder","year":"2015","unstructured":"Lodder J, Dena\u00ebs T, Chobert MN, Wan J, El-Benna J, Pawlotsky JM, et al. Macrophage autophagy protects against liver fibrosis in mice. Autophagy. 2015;11:1280\u201392.","journal-title":"Autophagy."},{"key":"801_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16602-0","volume":"11","author":"DS Leventhal","year":"2020","unstructured":"Leventhal DS, Sokolovska A, Li N, Plescia C, Kolodziej SA, Gallant CW, et al. Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity. Nat Commun. 2020;11:2739.","journal-title":"Nat Commun."},{"key":"801_CR34","doi-asserted-by":"publisher","first-page":"498","DOI":"10.7150\/thno.37745","volume":"10","author":"L Miao","year":"2020","unstructured":"Miao L, Qi J, Zhao Q, Wu QN, Wei DL, Wei XL, et al. Targeting the STING pathway in tumor-associated macrophages regulates innate immune sensing of gastric cancer cells. Theranostics. 2020;10:498\u2013515.","journal-title":"Theranostics."},{"key":"801_CR35","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.celrep.2015.04.031","volume":"11","author":"L Corrales","year":"2015","unstructured":"Corrales L, Glickman LH, McWhirter SM, Kanne DB, Sivick KE, Katibah GE, et al. Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity. Cell Rep. 2015;11:1018\u201330.","journal-title":"Cell Rep"},{"key":"801_CR36","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","volume":"41","author":"SR Woo","year":"2014","unstructured":"Woo SR, Fuertes MB, Corrales L, Spranger S, Furdyna MJ, Leung MY, et al. STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. Immunity. 2014;41:830\u201342.","journal-title":"Immunity."},{"key":"801_CR37","doi-asserted-by":"publisher","first-page":"7789","DOI":"10.1128\/JVI.01040-16","volume":"90","author":"CW Lio","year":"2016","unstructured":"Lio CW, McDonald B, Takahashi M, Dhanwani R, Sharma N, Huang J, et al. cGAS-STING signaling regulates initial innate control of cytomegalovirus infection. J Virol. 2016;90:7789\u201397.","journal-title":"J Virol."},{"key":"801_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13348","volume":"7","author":"LS Reinert","year":"2016","unstructured":"Reinert LS, Lopu\u0161n\u00e1 K, Winther H, Sun C, Thomsen MK, Nandakumar R, et al. Sensing of HSV-1 by the cGAS-STING pathway in microglia orchestrates antiviral defence in the CNS. Nat Commun. 2016;7:13348.","journal-title":"Nat Commun."},{"key":"801_CR39","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jhep.2013.03.019","volume":"59","author":"Q Ding","year":"2013","unstructured":"Ding Q, Cao X, Lu J, Huang B, Liu YJ, Kato N, et al. Hepatitis C virus NS4B blocks the interaction of STING and TBK1 to evade host innate immunity. J Hepatol. 2013;59:52\u201358.","journal-title":"J Hepatol."},{"key":"801_CR40","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1128\/AAC.04321-14","volume":"59","author":"F Guo","year":"2015","unstructured":"Guo F, Han Y, Zhao X, Wang J, Liu F, Xu C, et al. STING agonists induce an innate antiviral immune response against hepatitis B virus. Antimicrob Agents Chemother. 2015;59:1273\u201381.","journal-title":"Antimicrob Agents Chemother"},{"key":"801_CR41","doi-asserted-by":"publisher","first-page":"e00771","DOI":"10.1128\/AAC.00771-17","volume":"61","author":"F Guo","year":"2017","unstructured":"Guo F, Tang L, Shu S, Sehgal M, Sheraz M, Liu B, et al. Activation of stimulator of interferon genes in hepatocytes suppresses the replication of hepatitis B virus. Antimicrob Agents Chemother. 2017;61:e00771-17.","journal-title":"Antimicrob Agents Chemother"},{"key":"801_CR42","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1128\/JVI.02760-14","volume":"89","author":"Y Liu","year":"2015","unstructured":"Liu Y, Li J, Chen J, Li Y, Wang W, Du X, et al. Hepatitis B virus polymerase disrupts K63-linked ubiquitination of STING to block innate cytosolic DNA-sensing pathways. J Virol. 2015;89:2287\u2013300.","journal-title":"J Virol."},{"key":"801_CR43","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1002\/hep.28685","volume":"64","author":"MK Thomsen","year":"2016","unstructured":"Thomsen MK, Nandakumar R, Stadler D, Malo A, Valls RM, Wang F, et al. Lack of immunological DNA sensing in hepatocytes facilitates hepatitis B virus infection. Hepatology. 2016;64:746\u201359.","journal-title":"Hepatology."},{"key":"801_CR44","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1172\/JCI121842","volume":"129","author":"Y Yu","year":"2019","unstructured":"Yu Y, Liu Y, An W, Song J, Zhang Y, Zhao X. STING-mediated inflammation in Kupffer cells contributes to progression of nonalcoholic steatohepatitis. J Clin Invest. 2019;129:546\u201355.","journal-title":"J Clin Invest"},{"key":"801_CR45","doi-asserted-by":"publisher","first-page":"104933","DOI":"10.1016\/j.antiviral.2020.104933","volume":"183","author":"Q Zhu","year":"2020","unstructured":"Zhu Q, Hu H, Liu H, Shen H, Yan Z, Gao L. A synthetic STING agonist inhibits the replication of human parainfluenza virus 3 and rhinovirus 16 through distinct mechanisms. Antivir Res. 2020;183:104933.","journal-title":"Antivir Res"},{"key":"801_CR46","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1006\/viro.1999.9983","volume":"263","author":"P Keskinen","year":"1999","unstructured":"Keskinen P, Nyqvist M, Sareneva T, Pirhonen J, Mel\u00e9n K, Julkunen I. Impaired antiviral response in human hepatoma cells. Virology. 1999;263:364\u201375.","journal-title":"Virology."},{"key":"801_CR47","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1053\/j.gastro.2006.01.001","volume":"130","author":"T Pollicino","year":"2006","unstructured":"Pollicino T, Belloni L, Raffa G, Pediconi N, Squadrito G, Raimondo G, et al. Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones. Gastroenterology. 2006;130:823\u201337.","journal-title":"Gastroenterology."},{"key":"801_CR48","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1126\/science.1243462","volume":"343","author":"J Lucifora","year":"2014","unstructured":"Lucifora J, Xia Y, Reisinger F, Zhang K, Stadler D, Cheng X, et al. Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA. Science. 2014;343:1221\u20138.","journal-title":"Science."},{"key":"801_CR49","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1002\/hep.29479","volume":"66","author":"X Hong","year":"2017","unstructured":"Hong X, Kim ES, Guo H. Epigenetic regulation of hepatitis B virus covalently closed circular DNA: Implications for epigenetic therapy against chronic hepatitis B. Hepatology. 2017;66:2066\u201377.","journal-title":"Hepatology."},{"key":"801_CR50","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.jhep.2015.06.023","volume":"63","author":"L Rivi\u00e8re","year":"2015","unstructured":"Rivi\u00e8re L, Gerossier L, Ducroux A, Dion S, Deng Q, Michel ML, et al. HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase. J Hepatol. 2015;63:1093\u2013102.","journal-title":"J Hepatol."},{"key":"801_CR51","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1002\/hep.30897","volume":"71","author":"Y Yang","year":"2020","unstructured":"Yang Y, Zhao X, Wang Z, Shu W, Li L, Li Y, et al. Nuclear sensor interferon-inducible protein 16 inhibits the function of hepatitis B virus covalently closed circular DNA by integrating innate immune activation and epigenetic suppression. Hepatology. 2020;71:1154\u201369.","journal-title":"Hepatology."},{"key":"801_CR52","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/nature17170","volume":"531","author":"A Decorsi\u00e8re","year":"2016","unstructured":"Decorsi\u00e8re A, Mueller H, van Breugel PC, Abdul F, Gerossier L, Beran RK, et al. Hepatitis B virus X protein identifies the Smc5\/6 complex as a host restriction factor. Nature. 2016;531:386\u20139.","journal-title":"Nature."},{"key":"801_CR53","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s41579-020-0382-3","volume":"18","author":"K Tsai","year":"2020","unstructured":"Tsai K, Cullen BR. Epigenetic and epitranscriptomic regulation of viral replication. Nat Rev Microbiol. 2020;18:559\u201370.","journal-title":"Nat Rev Microbiol."},{"key":"801_CR54","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.4161\/auto.32178","volume":"10","author":"AK Giegerich","year":"2014","unstructured":"Giegerich AK, Kuchler L, Sha LK, Knape T, Heide H, Wittig I, et al. Autophagy-dependent PELI3 degradation inhibits proinflammatory IL1B expression. Autophagy. 2014;10:1937\u201352.","journal-title":"Autophagy."},{"key":"801_CR55","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/nature07383","volume":"456","author":"T Saitoh","year":"2008","unstructured":"Saitoh T, Fujita N, Jang MH, Uematsu S, Yang BG, Satoh T, et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature. 2008;456:264\u20138.","journal-title":"Nature."},{"key":"801_CR56","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/SHK.0000000000001259","volume":"52","author":"Z Wang","year":"2019","unstructured":"Wang Z, Li Z, Feng D, Zu G, Li Y, Zhao Y, et al. Autophagy induction ameliorates inflammatory responses in intestinal ischemia-reperfusion through inhibiting NLRP3 inflammasome activation. Shock. 2019;52:387\u201395.","journal-title":"Shock."},{"key":"801_CR57","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1126\/science.1190354","volume":"329","author":"T Hidvegi","year":"2010","unstructured":"Hidvegi T, Ewing M, Hale P, Dippold C, Beckett C, Kemp C, et al. An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis. Science. 2010;329:229\u201332.","journal-title":"Science"},{"key":"801_CR58","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41419-019-1311-0","volume":"10","author":"D Jia","year":"2019","unstructured":"Jia D, Wang YY, Wang P, Huang Y, Liang DY, Wang D, et al. SVIP alleviates CCl4-induced liver fibrosis via activating autophagy and protecting hepatocytes. Cell Death Dis. 2019;10:71.","journal-title":"Cell Death Dis."},{"key":"801_CR59","doi-asserted-by":"publisher","first-page":"629","DOI":"10.4161\/auto.7.6.15100","volume":"7","author":"J Haspel","year":"2011","unstructured":"Haspel J, Shaik RS, Ifedigbo E, Nakahira K, Dolinay T, Englert JA, et al. Characterization of macroautophagic flux in vivo using a leupeptin-based assay. Autophagy. 2011;7:629\u201342.","journal-title":"Autophagy."},{"key":"801_CR60","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1053\/j.gastro.2010.08.020","volume":"140","author":"J Petrasek","year":"2011","unstructured":"Petrasek J, Dolganiuc A, Csak T, Kurt-Jones EA, Szabo G. Type I interferons protect from Toll-like receptor 9-associated liver injury and regulate IL-1 receptor antagonist in mice. Gastroenterology. 2011;140:697\u2013708.","journal-title":"Gastroenterology."},{"key":"801_CR61","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/hep.26981","volume":"60","author":"YS Roh","year":"2014","unstructured":"Roh YS, Park S, Kim JW, Lim CW, Seki E, Kim B. Toll-like receptor 7-mediated type I interferon signaling prevents cholestasis- and hepatotoxin-induced liver fibrosis. Hepatology. 2014;60:237\u201349.","journal-title":"Hepatology."},{"key":"801_CR62","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.ajpath.2019.11.012","volume":"190","author":"Z Zhou","year":"2020","unstructured":"Zhou Z, Kim JW, Qi J, Eo SK, Lim CW, Kim B. Toll-like receptor 5 signaling ameliorates liver fibrosis by inducing interferon beta-modulated IL-1 receptor antagonist in mice. Am J Pathol. 2020;190:614\u201329.","journal-title":"Am J Pathol."},{"key":"801_CR63","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.jhep.2017.12.007","volume":"68","author":"C Niu","year":"2018","unstructured":"Niu C, Li L, Daffis S, Lucifora J, Bonnin M, Maadadi S, et al. Toll-like receptor 7 agonist GS-9620 induces prolonged inhibition of HBV via a type I interferon-dependent mechanism. J Hepatol. 2018;68:922\u201331.","journal-title":"J Hepatol"},{"key":"801_CR64","doi-asserted-by":"publisher","first-page":"312","DOI":"10.7326\/0003-4819-119-4-199308150-00011","volume":"119","author":"DKH Wong","year":"1993","unstructured":"Wong DKH. Effect of alpha-interferon treatment in patients with hepatitis B antigen-positive chronic hepatitis B. A meta-analysis. Ann Intern Med. 1993;119:312\u201323.","journal-title":"Ann Intern Med."},{"key":"801_CR65","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/cr.2013.47","volume":"23","author":"K Fink","year":"2013","unstructured":"Fink K, Martin L, Mukawera E, Chartier S, De Deken X, Brochiero E, et al. IFNbeta\/TNFalpha synergism induces a non-canonical STAT2\/IRF9-dependent pathway triggering a novel DUOX2 NADPH oxidase-mediated airway antiviral response. Cell Res. 2013;23:673\u201390.","journal-title":"Cell Res"},{"key":"801_CR66","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1172\/JCI58847","volume":"122","author":"L Belloni","year":"2012","unstructured":"Belloni L, Allweiss L, Guerrieri F, Pediconi N, Volz T, Pollicino T, et al. IFN-alpha inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome. J Clin Investig. 2012;122:529\u201337.","journal-title":"J Clin Investig."},{"key":"801_CR67","first-page":"1455","volume":"122","author":"X Liu","year":"2009","unstructured":"Liu X, Zhu ST, You H, Cong M, Liu TH, Wang BE, et al. Hepatitis B virus infects hepatic stellate cells and affects their proliferation and expression of collagen type I. Chin Med J. 2009;122:1455\u201361.","journal-title":"Chin Med J"},{"key":"801_CR68","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1053\/j.gastro.2012.09.008","volume":"143","author":"P Kubes","year":"2012","unstructured":"Kubes P, Mehal WZ. Sterile Inflammation in the Liver. Gastroenterology. 2012;143:1158\u201372.","journal-title":"Gastroenterology."},{"key":"801_CR69","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/hep.30990","volume":"72","author":"K Song","year":"2020","unstructured":"Song K, Kwon H, Han C, Chen W, Zhang J, Ma W, et al. Yes-associated protein in kupffer cells enhances the production of proinflammatory cytokines and promotes the development of nonalcoholic steatohepatitis. Hepatology. 2020;72:72\u201387.","journal-title":"Hepatology."},{"key":"801_CR70","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1053\/j.gastro.2012.03.006","volume":"142","author":"LR Huang","year":"2012","unstructured":"Huang LR, G\u00e4bel YA, Graf S, Arzberger S, Kurts C, Heikenwalder M, et al. Transfer of HBV genomes using low doses of adenovirus vectors leads to persistent infection in immune competent mice. Gastroenterology. 2012;142:1447\u201350.","journal-title":"Gastroenterology."},{"key":"801_CR71","doi-asserted-by":"publisher","first-page":"8045","DOI":"10.1128\/JVI.01024-14","volume":"88","author":"Z Qi","year":"2014","unstructured":"Qi Z, Li G, Hu H, Yang C, Zhang X, Leng Q, et al. Recombinant covalently closed circular hepatitis B virus DNA induces prolonged viral persistence in immunocompetent mice. J Virol. 2014;88:8045\u201356.","journal-title":"J Virol."},{"key":"801_CR72","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.jhep.2016.12.018","volume":"66","author":"X Yu","year":"2017","unstructured":"Yu X, Lan P, Hou X, Han Q, Lu N, Li T, et al. HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1beta production via suppressing the NF-kappaB pathway and ROS production. J Hepatol. 2017;66:693\u2013702.","journal-title":"J Hepatol."},{"key":"801_CR73","doi-asserted-by":"publisher","first-page":"4580","DOI":"10.1128\/JVI.76.9.4580-4590.2002","volume":"76","author":"AK Zaiss","year":"2002","unstructured":"Zaiss AK, Liu Q, Bowen GP, Wong NC, Bartlett JS, Muruve DA. Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors. J Virol. 2002;76:4580\u201390.","journal-title":"J Virol."},{"key":"801_CR74","doi-asserted-by":"publisher","first-page":"104826","DOI":"10.1016\/j.antiviral.2020.104826","volume":"180","author":"M Wu","year":"2020","unstructured":"Wu M, Wang C, Shi B, Fang Z, Qin B, Zhou X, et al. A novel recombinant cccDNA-based mouse model with long term maintenance of rcccDNA and antigenemia. Antivir Res. 2020;180:104826.","journal-title":"Antivir Res"},{"key":"801_CR75","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/sj.gt.3302036","volume":"10","author":"Q Liu","year":"2003","unstructured":"Liu Q, Muruve DA. Molecular basis of the inflammatory response to adenovirus vectors. Gene Ther. 2003;10:935\u201340.","journal-title":"Gene Ther"},{"key":"801_CR76","doi-asserted-by":"publisher","first-page":"10806","DOI":"10.1128\/JVI.00675-11","volume":"85","author":"KA McGuire","year":"2011","unstructured":"McGuire KA, Barlan AU, Griffin TM, Wiethoff CM. Adenovirus type 5 rupture of lysosomes leads to cathepsin B-dependent mitochondrial stress and production of reactive oxygen species. J Virol. 2011;85:10806\u201313.","journal-title":"J Virol."},{"key":"801_CR77","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1089\/10430349950018364","volume":"10","author":"DA Muruve","year":"1999","unstructured":"Muruve DA, Barnes MJ, Stillman IE, Libermann TA. Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo. Hum Gene Ther. 1999;10:965\u201376.","journal-title":"Hum Gene Ther."},{"key":"801_CR78","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.cell.2017.09.039","volume":"171","author":"MM Gaidt","year":"2017","unstructured":"Gaidt MM, Ebert TS, Chauhan D, Ramshorn K, Pinci F, Zuber S, et al. The DNA inflammasome in human myeloid cells is initiated by a STING-cell death program upstream of NLRP3. Cell. 2017;171:1110\u201324.","journal-title":"Cell."},{"key":"801_CR79","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1053\/j.gastro.2018.09.010","volume":"155","author":"X Luo","year":"2018","unstructured":"Luo X, Li H, Ma L, Zhou J, Guo X, Woo SL, et al. Expression of STING is increased in liver tissues from patients with NAFLD and promotes macrophage-mediated hepatic inflammation and fibrosis in mice. Gastroenterology. 2018;155:1971\u201384.","journal-title":"Gastroenterology."},{"key":"801_CR80","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.cld.2016.06.003","volume":"20","author":"DC Rockey","year":"2016","unstructured":"Rockey DC. Liver fibrosis reversion after suppression of hepatitis B virus. Clin Liver Dis. 2016;20:667\u201379.","journal-title":"Clin Liver Dis"},{"key":"801_CR81","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1128\/JVI.01720-15","volume":"90","author":"G Yi","year":"2016","unstructured":"Yi G, Wen Y, Shu C, Han Q, Konan KV, Li P, et al. Hepatitis C virus NS4B can suppress STING accumulation to evade innate immune responses. J Virol. 2016;90:254\u201365.","journal-title":"J Virol"},{"key":"801_CR82","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/j.1365-2567.2007.02672.x","volume":"122","author":"J Tanabe","year":"2007","unstructured":"Tanabe J, Izawa A, Takemi N, Miyauchi Y, Torii Y, Tsuchiyama H, et al. Interferon-beta reduces the mouse liver fibrosis induced by repeated administration of concanavalin A via the direct and indirect effects. Immunology. 2007;122:562\u201370.","journal-title":"Immunology."},{"key":"801_CR83","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/cmi.2014.110","volume":"12","author":"Y Xiao","year":"2015","unstructured":"Xiao Y, Liu F, Yang J, Zhong M, Zhang E, Li Y, et al. Over-activation of TLR5 signaling by high-dose flagellin induces liver injury in mice. Cell Mol Immunol. 2015;12:729\u201342.","journal-title":"Cell Mol Immunol."},{"key":"801_CR84","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41580-018-0003-4","volume":"19","author":"I Dikic","year":"2018","unstructured":"Dikic I, Elazar Z. Mechanism and medical implications of mammalian autophagy. Nat Rev Mol Cell Biol. 2018;19:349\u201364.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"801_CR85","doi-asserted-by":"crossref","unstructured":"Kegel V, Daniela D, Pfeiffer E, Zeilinger K, Seehofer D, Damm G, et al. Protocol for isolation of primary human hepatocytes and corresponding major populations of non-parenchymal liver cells. J Vis Exp. 2016: e53069.","DOI":"10.3791\/53069"},{"key":"801_CR86","doi-asserted-by":"publisher","first-page":"e00001","DOI":"10.1128\/JVI.00001-17","volume":"91","author":"L Zhong","year":"2017","unstructured":"Zhong L, Shu W, Dai W, Gao B, Xiong S. Reactive oxygen species-mediated c-Jun NH2-terminal kinase activation contributes to hepatitis B virus X protein-induced autophagy via regulation of the Beclin-1\/Bcl-2 interaction. J. Virol. 2017;91:e00001-17.","journal-title":"J. Virol."},{"key":"801_CR87","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/0022-2836(67)90307-5","volume":"26","author":"B Hirt","year":"1967","unstructured":"Hirt B. Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol. 1967;26:365\u20139.","journal-title":"J Mol Biol"}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-021-00801-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-021-00801-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-021-00801-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T06:06:37Z","timestamp":1666764397000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-021-00801-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,22]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["801"],"URL":"https:\/\/doi.org\/10.1038\/s41423-021-00801-w","relation":{},"ISSN":["1672-7681","2042-0226"],"issn-type":[{"value":"1672-7681","type":"print"},{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,22]]},"assertion":[{"value":"23 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}